EGFR and malignant colon neoplasm: It is also likely that EGFR is one of the target molecules for the rTBL-1, and many other membrane glycoproteins could be interacting, as aberrant sialylation and fucosylation are common in other glycoproteins involved in the development of many types of cancers, including colon cancer.